CollPlant Biotechnologies (CLGN) Exchange Rate Effect (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Exchange Rate Effect of $7000.0 for Q1 2026, up 600.0% on a YoY basis from $1000.0 in Q1 2025, and up 216.67% quarter-over-quarter from -$6000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Exchange Rate Effect (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Exchange Rate Effect for 9 years, with the latest figure at $7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 600.0% year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $32000.0 (up 277.78% YoY), and the FY2025 full-year result was $26000.0, up 118.31% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $7000.0, up from -$6000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $199000.0 in Q4 2023, with the low at -$969000.0 in Q1 2022.
- Historically, Exchange Rate Effect has averaged -$332058.8 across 5 years, with a median of -$118000.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 2384.62% — and 2026, when it surged 600.0%.
- CollPlant Biotechnologies' Exchange Rate Effect stood at -$608000.0 in 2022, then soared by 132.73% to $199000.0 in 2023, then sank by 69.85% to $60000.0 in 2024, then tumbled by 110.0% to -$6000.0 in 2025, then soared by 216.67% to $7000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $7000.0 (Q1 2026), -$6000.0 (Q4 2025), and -$9000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 60,000.00 |
| Dec 31, 2024 | 60,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | -118,000.00 |
| Jun 30, 2024 | -118,000.00 |
| Mar 31, 2024 | -123,000.00 |
| Mar 31, 2024 | -123,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Dec 31, 2023 | 199,000.00 |